Awards BU’s Kenneth Lutchen Named AAAS Fellow The Brink | April 4, 2025 A scholar at the forefront of respiratory mechanics and an innovative leader in higher education,…karnottApril 4, 2025 Read More
Local News Building Bridges Between Denmark-Based and Broad Researchers The Broad Institute | April 3, 2025 When Maddie Murphy, a computational associate at the Broad Institute of MIT and Harvard, first…karnottApril 3, 2025 Read More
Awards MIT Affiliates Named 2024 AAAS Fellows MIT Chemistry | April 3, 2025 Six current MIT affiliates and 27 additional MIT alumni have been elected as fellows of…karnottApril 3, 2025 Read More
Local News Probing the Mysteries of the Aging Brain Harvard Medical School | April 2, 2025 Sixteen years ago, Michael Segel was a rising senior at Brookline High School in Massachusetts…karnottApril 2, 2025 Read More
Publications of the Week Enteric Neuronal Piezo1 Maintains Mechanical and Immunological Homeostasis by Sensing Force Xie, Z., et al. | April 2, 2025 The gastrointestinal (GI) tract experiences a myriad of mechanical forces while orchestrating digestion and barrier…karnottApril 2, 2025 Read More
Local News Sandy Elmehrath on Closing the Gender Health Gap by Driving Progress in Endometriosis Management and Care Wyss Institute | April 1, 2025 Sandy Elmehrath is all too familiar with the consequences of the gender health gap. Her…karnottApril 1, 2025 Read More
Awards Dulac Lab Postdocs Awarded Grants From NIH and Brain & Behavior Research Foundation Harvard University Department of Molecular and Cellular Biology | April 1, 2025 Two postdocs from the Dulac Lab have recently been awarded fellowships. Changwoo Seo was selected…karnottApril 1, 2025 Read More
Awards CMIT Clinical Scientist Receives IBD Journal Award The Center for Microbiome Informatics & Therapeutics (CMIT) | March 31, 2025 CMIT Clinical Scientist Marjolein Klaassen, MD, PhD was selected for the Inflammatory Bowel Diseases journal’s…karnottMarch 31, 2025 Read More
Local News FDA Approves Dual-Action Drug for Patients With Previously Treated Advanced Neuroendocrine Tumors, Backed by Dana-Farber Research Dana-Farber Cancer Institute | March 31, 2025 Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug…karnottMarch 31, 2025 Read More
Local News Engineers Develop a Better Way To Deliver Long-Lasting Drugs MIT News | March 31, 2025 MIT engineers have devised a new way to deliver certain drugs in higher doses with…karnottMarch 31, 2025 Read More